Clinical Trial Update: Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial of sitravatinib, with or without other anticancer therapies, has completed and is reporting clinical benefit observed in the parent stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Solid Malignancies

Drugs mentioned

• Sitravatinib (sitravatinib)

Snippet

Sponsor: Mirati Therapeutics Inc. | Conditions: Advanced or Metastatic Solid Malignancies | Phase 2, Phase 3 | Status: COMPLETED